Page results
-
University College Hospital's Outpatients department sees many patients, covering a variety of different specialties.
-
Contact details of clinical lead adults and lead paediatrics
-
Information for the Camden Sickle Cell and Thalassaemia Service
-
Next generation testing, artificial intelligence, advanced mass spectrometry and machine learning is about to be used for diagnostics in the U.K. thanks to a new partnership between UCLH and Guilford Street Laboratories (GSL).
-
The full integration of intra-oral scanners with Epic improves efficiency and enhances patient experience by significantly reducing appointment times and appointment-to-treatment times so patients receive the right care faster.
-
A cancer treatment that is currently available to only a limited number of UK patients is to be tested at UCLH in a countrywide clinical trial to see if it causes fewer long-term side effects than standard radiotherapy.
-
Sonya Moudart has been appointed as a Mesothelioma UK Clinical Nurse Specialist at UCLH. In her new role, Sonya will provide care and support for mesothelioma (asbestos-related cancer) patients and in time, will be a beacon of expertise in all matters relating to mesothelioma for the North Central London Cancer Alliance area.
-
The Com-Cov trial in which UCLH is a site looking at alternating vaccines has been expanded to include the Moderna and Novavax vaccines.
-
I worked as a senior directorate accountant in finance in the NHS across a wide range of directorates, both corporate and clinical areas, working closely with these directorates on their financial plans, monitoring and forward planning.
-
We are excited to share news that Genomics England has launched an initiative that will directly benefit patients from underrepresented populations such as those living with sickle cell disorder.
File results
-
FOI/2022/0254 - Patient treatment/ surgery
-
FOI/2022/0263 - Rheumatology prescriptions
-
FOI/2022/0267 - Performance data for the CCG2 CQUIN - Antibiotic prescribing for UTI in adults aged 16+
-
FOI/2022/0270 - Local care record/ shared care record implementation
-
FOI/2022/0274 - Patient treatment for various conditions
-
FOI/2022/0275 - Biologic medications within dermatology
-
FOI/2022/0276 - Biologic medicines within dermatology
-
FOI/2022/0278 - Surgical tables in use at Trust
-
FOI/2022/0280 - Applications or tools to communicate digitally with patients
-
FOI/2022/0282 - Decontamination and infection control leads; risk assessment group meetings